Posted in General 
July 10th, 2009

Labopharm Inc. (Nasdaq: DDSS) shares are up nearly 4 percent on volume of about 12,000 shares in premarket trading around 8:15 a.m. Eastern. There is nothing new that we’ve found on the stock this morning. But relative volume has increased more than two-fold over its monthly average this week.  The company expects to hear from the FDA in coming weeks if its Trazodone OD once-daily depression drug will be approved in the U.S. — Mike Tarsala

Comments are closed